Vancouver, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The global Lyme disease treatment market size was USD Million 850.0 in 2022 and is expected to register a revenue CAGR of 8.5% during the forecast period, according to latest analysis by Emergen Research. Increasing investment by major companies and rising development in healthcare facilities and diagnostic procedures across the globe are projected to support revenue growth of the Lyme disease treatment market during the forecast period. For both people and animals suspected of having been in touch with the disease, the greater accuracy of Spectroscopic testing may improve diagnosis procedures for Lyme disease.
The new test could benefit mobile veterinary services for animals because it would just need a random subset that could be conveniently collected outside of a veterinarian clinic or hospital. Raman spectroscopy testing for humans has the potential to greatly reduce the time required for testing, increase the precision of the diagnosis, reduce the cost of making the diagnostic, and enhance overall health by making the disease diagnosis earlier.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1621
An estimated 476,000 Americans get infected with Lyme disease each year, an illness that can have a variety of symptoms like fever, rash, and joint discomfort as well as negative consequences on the heart and central nervous system. Although antibiotic treatments for Lyme disease are successful, it is common in North America, Europe, and Asia. In some individuals, symptoms can last for months or even years despite antibiotic treatment.
The most significant element that confuses a patient's subsequent western blot treatment is misdiagnosis, which is hampering revenue growth of the market.
Scope of Research
| Report Details | Outcome |
| Market Size in 2022 | USD 805.0 Million |
| CAGR (2023–2032) | 8.5% |
| Revenue Forecast to 2032 | USD 1,826.36 Million |
| Base Year for Estimation | 2022 |
| Historical Data | 2019–2021 |
| Forecast Period | 2023–2032 |
| Quantitative Units | Revenue in USD Million and CAGR in % from 2023 to 2032 |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered | Treatment type, administration route, distribution channel, application, and region |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
| Country Scope | U.S., Canada, Mexico, Germany, France, UK, Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, and Rest of Middle East & Africa |
| Key Companies Profiled | GSK plc., Pfizer Inc., Sun Pharmaceuticals Industries Ltd., Novartis AG, Lupin Pharmaceuticals, Inc., Perrigo Company plc, ChartwellPharma, Mayne Pharma Group Limited, Almirall, S.A, Orion Oyj |
| Customization Scope | 10 hours of free customization and expert consultation |
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1621
Major Companies and Competitive Landscape
The global Lyme disease treatment market is consolidated with small and large-sized companies accounting for the majority of market revenue. Major companies are deploying various strategies, entering mergers & acquisitions, strategic agreements & contracts, and developing, testing, and introducing more effective Lyme disease treatments. Some major companies included in the global Lyme disease treatment market report are:
- GSK plc.
- Pfizer Inc.
- Sun Pharmaceuticals Industries Ltd.
- Novartis AG
- Lupin Pharmaceuticals, Inc.
- Perrigo Company plc
- ChartwellPharma
- Mayne Pharma Group Limited
- Almirall, S.A
- Orion Oyj
Strategic Development
- On 16 June 2021, an innovative, verbal, non-vaccine therapeutic for the prevention of Lyme disease called TP-05 has begun dosing participants in Tarsus Pharmaceuticals, Inc.'s first clinical trial. The company is a late-stage biopharmaceutical company to focus on unmet needs and revolutionizes patient treatment, starting with eye care. An only one elevated dose and numerous ascending dose trials, the Phase 1 Callisto trial examines the Pharmacokinetics (PK) of TP-05 in healthy subjects.
Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1621
Some Key Highlights From the Report
- The animal segment is expected to register the second-largest revenue CAGR during the forecast period. The prevalence of Lyme disease in small animals has significantly increased. Diagnostic and therapeutic efforts are highly required, particularly in dogs. Stridently, the rise in owning a pet will broaden opportunities for major companies in the market.
- The medication segment is expected to register the largest revenue CAGR during the forecast period. Most instances of early Lyme disease are successfully treated with a provides the direction of oral antibiotics such as doxycycline or amoxicillin. With four weeks of antibiotic medication, Lyme disease is successfully cured in more severe cases.
- Market in North America accounted for the largest revenue share in 2022. Although preventative methods, such as using repellant and inspecting for ticks, are advised to aid in personal protection, there is little proof that they are influencing the annual number of Lyme disease cases.
- On 08 August 2022, the phase three clinical trial of Vaccine Against Lyme for Outdoors Recreationists (VALOR) was launched by Pfizer Inc. and Valneva SE to examine the efficacy, safety, and immunology of their experimental Lyme disease vaccine candidate, VLA15.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/lyme-disease-treatment-market
Emergen Research has segmented the global Lyme disease treatment market on the basis of treatment type, administration route, distribution channel, application, and region:
- Treatment Type Outlook (Revenue, USD Million; 2019–2032)
- Medication
- Tick Removal
- Administration Route Outlook (Revenue, USD Million; 2019–2032)
- Oral
- Injectable
- Topical
- Distribution Channel Outlook (Revenue, USD Million; 2019–2032)
- Hospital
- Retail
- Online
- Application Outlook (Revenue, USD Million; 2019–2032)
- Human
- Animal
- Regional Outlook (Revenue, USD Million; 2019–2032)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Benelux
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Turkey
- Rest of MEA
- North America
Curated Reports You Shouldn't Miss: Dive In Now!
Viral Vector and Plasmid Manufacturing Market, By Vector Type (Plasmid DNA, AAV), By Disease Type (Cancer, Genetic Disorder), By Application (Gene Therapy, Cell Therapy), By End-Use, and By Region Forecast to 2030
Orthopedics Devices Market By Product, By Type (Joint Reconstruction, Spinal, Trauma, Arthroscopy, Dental Implants, Orthobiologics), By Application (Hip, Knee, Spine, Cranio-Maxillofacial (CMF), Dental, Sports Medical, Extremities, and Trauma (SET)), Forecasts to 2027
Radiation Dose Management Market, By Product (Dosimeters, Area Process Monitors), By Component (Software, Service), By Application (Radiography, Angiography, Mammography), and By Region Forecast to 2030
In Vitro Fertilization Market Size, Share, Trends, By Procedure (Fresh Donor, Fresh Non-Donor, Frozen Donor, Frozen Non-Donor), By Product (Reagents, Equipment), By End-use (Hospitals and Research Laboratories, Fertility Clinics and Surgical Centers, Cryobanks), and By Region Forecast to 2028
Direct-To-Consumer Genetic Testing Market, By Test Type (Carrier Testing and Predictive Testing), By Technology (Targeted Analysis and Whole Genome Sequencing), and By Region Forecast to 2030
Orthodontics Market, By Product Type (Instruments, Supplies), By End-Use (Hospitals, Dental Clinics, Others), and By Region Forecast to 2030
Medical Image Analytics Market By Modality (Tomography, Ultrasound Imaging, Radiographic Imaging, Combined Modalities), By Imaging Type (2D, 3D, 4D Imaging), By Application (Orthopedic, Dental, Neurology, Cardiology, Oncology, Obstetrics & Gynecology) and By Regions Forecasts to 2027
Clinical Biomarkers Market Size, Share, Trends, By Type (Safety, Efficacy, Validation), By Disease (Cancer, Cardiovascular Diseases, Neurological Diseases, Immunological Diseases), By Application, By Region, Forecast to 2027
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: https://www.emergenresearch.com/
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Explore Our Japanese Version: Lyme Disease Treatment Market
Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights
Read our Press Release @ https://www.emergenresearch.com/press-release/global-lyme-disease-treatment-market
